Roles of cytokines and growth factors in liver regeneration, repair, and fibrosis after liver injury

Drug-Induced Liver Disease

Volumn , Issue , 2002, Pages 213-226

  Taub, Rebecca ^a   Bansal, Meena ^a   Lei, Wei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056690479     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
2. Taub R, Greenbaum LE, Peng Y. Transcriptional regulation signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 1999; 19(2):117-127.
3. Taub R. Liver regeneration in health and disease. Clin Lab Med 1996; 16:341-360.
4. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 1996; 10:413-427.
5. Leu JI, Crissey MAS, Leu JP, Ciliberto G, Taub R. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 2001; 21(2):414-424.
6. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of posthepatectomy factor/nuclear factor-KB in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994; 269:30429-30435.
7. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of the STAT3 transcription complex in liver regeneration. Hepatology 1995; 21:1443-1449.
8. Taga T, Kishomoto T. GP130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997; 15:797-819.
9. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274:1379-1383.
10. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagbt GJ, Diehl AM. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263:G579-G585.
11. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: defective liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997; 94:1441-1446.
12. Greenbaum LE, Li W, Cressman DE, Ciliberto G, Poli V, Taub R. CCAAT enhancer-binding protein b is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998; 102:996-1007.
13. Fausto N. Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: Present and future. Am Physiol Soc 1999; 277:G917-G921.
14. Smith AJ, Elferink PJOE. Liver gene disruption: winners by KO? J Hepatol 1999; 31:752-759.
15. Loranger A, Duclos S, Grenier A, Price J, Wilson-Heiner M, Baribault H, Marceau N. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol 1997; 151(6):1673-1683.
16. Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, Zhang J, Horton HF, Scott A, Orkin SH, Byrne MC, Grusby MJ, Glimcher LH. An essential role in liver development for transcription factor XBP-1. Genes Dev 2000; 14:152-157.
17. Rai RM, Lee FYJL, Rosen A, Yang SQ, Lin HZ, Koteish A, Liew FY, Zaragoza C, Lowenstein C, Diehl AM. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA 1998; 95:13829-13834.
18. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000; 287:1253-1258.
19. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med 1999; 5(2):226-230.
20. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997; 26(1):81-89.
21. Burr AW, Toole K, Chapman C, Hines JE, Burt AD. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J Pathol 1998; 185:298-302.
22. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31(1):149-159.
23. Camargo CA, Madden JF, Gao W, Selvan RS, Clavien P. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26(6):1513-1520.
24. Selzner M, Camargo CA, Clavien P-A. Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of interleukin-6. Hepatology 1999; 30(2):469-475.
25. Ezure T, Sakamoto T, Tsuji H, Lunz JG 3rd, Murase N, Fung JJ, Demetris AJ. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 2000; 156:1627-1639.
26. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999; 29(2):403-411.
27. Debonera F, Aldeguer X, Shen X, Gelman AE, Gao F, Que X, Greenbaum LE, Furth EE, Taub R, Olthoff KM. Activation of IL-6/STAT3 and liver regeneration following transplantation. J Surgical Res 2001; 96:289-295.
28. Berger ML, Bhatt H, Combes B, Estabrook R. CCl^-induced toxicity in isolated hepatocytes: the importance of direct solvent injury. Hepatology 1966; 6:36-45.
29. Slater TF. Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation. Nature 1966; 209:36-40.
30. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998; 153:515-525.
31. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995; 108:1849-1854.
32. Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 1998; 152:1577-1589.
33. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nature Med 1997; 3:409-413.
34. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274:782-784.
35. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995; 376:167-170.
36. Mizuhara H, O’Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, Senoh H, Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179:1529-1537.
37. Ravi R, Bedi A, Fuchs EJ, Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kB. Cancer Res 1998; 58:882-886.
38. Liu J, Li H, De Tribolet N, Jaufeerally R, Hamou MF, Van Meir EG. IL-6 stimulates growth and inhibits constitutive, protein synthesis-independent apoptosis of murine B-cell hybridoma 7TD1. Cell Immunol 1994; 155:428-435.
39. Smith MR, Xie T, Joshi I, Schilder RJ. Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells. Br J Haematol 1998; 102:1090-1097.
40. WAF1, CIP1, SDI1 gene by interleukin-6 type cytokines. J Biol Chem 1998; 273:21137-21144.
41. 1. Cancer Res 1995; 55:2262-2265.
42. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996; 5:449-460.
43. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liv Dis 1990; 10:56-65.
44. Brenner DA, Veloz L, Jaenisch R, Alcorn JM. Stimulation of the collagen alpha 1 (I) endogenous gene and transgene in carbon tetrachloride-induced hepatic fibrosis. Hepatology 1993; 17:287-292.
45. Ogawa M, Mori T, Mori Y, Ueda S, Azemoto R, Makino Y, Ohto M, Wakashin M, Yoshida H et al. Study on chronic renal injuries induced by carbon tetrachloride: selective inhibition of the nephrotoxicity by irradiation. Nephron 1992; 60:68-73.
46. Olufemi Williams S, Knapton AD. Hepatic silicosis, cirrhosis, and liver tumors in mice and hamsters: studies of transforming growth factor b expression. Hepatology 1996; 23:1268-1275.
47. Johnson LA, Wirostko E, Wirostko BM. Experimental murine chronic hepatitis: results following intrahepatic inoculation of human uveitis mycoplasma-like organisms. Int J Exp Pathol 1993; 74:325-331.
48. Friedman SL. Cytokines and fibrinogenesis. Semin Liver Dis 1999; 19(2):129-140.
49. Davis BH, Kresina TF. Hepatic fibrogenesis. Clin Lab Med 1996; 16:361-375.
50. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102:538-549.
51. Natsume M, Tsuji H, Harada A, Akiyama M, Yano T, Ishikura H, Nakanishi I, Matsushima K, Kaneko S, Mukaida N. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J Leukoc Biol 1999; 66:601-608.
52. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Fabbioni R, Fantuzzi G, Ghezzi P, Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994; 180:1243-1250.
53. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368:339-342.
54. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340(6):448-454.
55. Takahara T, Furui K, Tata Y, Jin B, Zhang LP, Nanbu S, Sato H, Seiki M, Watanabe A. Dual expression of matrix metalloproteinase in fibrotic human livers. Hepatology 1997; 26(6): 1521-1529.
56. Nagase H. Matrix metalloproteinases. J Biol Chem 1999; 274:21491-21494.
57. Bansal MB, Kovalovich K, Li W, Taub R. The biologic interplay between IL-6 and MMP-2 in modulating hepatic injury and fibrosis. Hepatology 2000; 32(4):110A.
58. Nagase H, Itoh Y, Binner S. Interaction of alpha-2 macroglobulin with matrix metalloproteinases and its use for identification of their active fors. Ann NY Acad Sci 1994; 732:294-302.
59. Li W, Liang X, Lev J, Kovalovich K, Ciliberto G, Taub R. Global changes in interleukin-6 dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 2001; 33:1377-1386.